drugset / Trial / NCT03100136

Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer

NCT03100136 ↗

Phase 1 Completed 7 enrolled Pfizer
NaSingle-groupOpen-labelOther

Summary

This is a study measuring the binding kinetics and test-retest characteristics of a subpharmacological dose of \[11C\]PF-06809247 Monoacylglycerol lipase (MAGL) Positron Emission Tomography (PET) tracer in healthy adult subjects.

Timeline

Start
2016-11-16
Primary completion
2017-03-10
Completion
2017-03-10

Drugs

EvaluationDrugModalityDoseRoute
Subject [11C]PF-06809247 Diagnostic / imaging agent — Intravenous

Indications